Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

DOR BioPharma Receives EMEA Agreement On The Design Of Its Confirmatory Phase 3 Clinical Trial Of OrBec(R) In GI GVHD
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biopharmaceutical company, announced that it has received Protocol Assistance feedback from the European Medicines Agency (EMEA) on the design of its confirmatory, pivotal, Phase 3 clinical trial evaluating its lead product orBec(R) for the treatment of acute gastrointestinal Graft-versus-Host Disease (GI GVHD).
generic viagra online
Sandvik Announces European Center Of Excellence
Swedish global industrial group, Sandvik, is announcing the development of the new Sandvik European Center of Excellence (SECoE) for finish processing and supply management activities for orthopedic implants and instruments.
News of the day
Lessons From The Vaccine-Autism Wars
Researchers long ago rejected the theory that vaccines cause autism, yet
Medical Devices

Swine Flu Update Issued On Monday 29 June 2009, Wales

with the antiviral oseltamavir (Tamiflu®) and zanamivir (Relenza®). -- Further information on swine flu and Pandemic Flu is available bilingually from http://www.nphs.wales.nhs.uk -- Further information from the Welsh Assembly Government response is available bilingually at http://www.wales.gov.uk Welsh Assembly Government

Pages: 1 [2] 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009